Another report showed that the combination of IL-21 with either CpG oligodeoxynucleotides or anti-B cell-receptor antibodies induce functional granzyme B expression, in B-CLL cells. This evidence concerns the gene IL21 and B-cell chronic lymphocytic leukemia.